Skip to content
Clinical Trials – home
SloveniaBack to Slovenia

Clinical trials in Golnik

9 clinical trials in Golnik, Slovenia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SloveniaOur site in SloveniaKlinicnaPreskusanja.si(opens in a new tab)
Golnik at a glance
9
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

9 trials in Golnik

Open in trial search
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:SloveniaSlovenia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amoxicillin Sodium
  • Sponsor:Universitair Medisch Centrum Utrecht
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Atuliflapon
  • Sponsor:AstraZeneca AB
Countries:SloveniaSlovenia
  • Participants:65+ years
  • Substances:Bi 1015550
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 1015550
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:SloveniaSlovenia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC
Countries:SloveniaSlovenia
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Other cities in Slovenia

The busiest research cities in the country

All 17 cities in Slovenia

Clinical research in Golnik

What the registry says about research in the country

01 Respiratory Diseases

Innovative research focusing on severe asthma treatments, evaluating new therapeutic approaches for patients with moderate to severe uncontrolled conditions. Multiple trials are examining novel medications and their effectiveness in managing eosinophilic phenotypes.

  • Uncontrolled Asthma Management
  • Eosinophilic Phenotype Studies
  • Long-term Treatment Evaluation

These studies aim to improve quality of life for patients with persistent respiratory symptoms.

02 Lung Cancer Research

Comprehensive studies on Non-Small Cell Lung Cancer (NSCLC), including early-stage and advanced cases. Trials are investigating innovative immunotherapy combinations and treatment approaches for various stages of the disease.

  • Early-Stage NSCLC Treatment
  • Immunotherapy Combinations
  • Post-surgical Therapy

Research focuses on improving survival rates and treatment outcomes for lung cancer patients.

03 Pulmonary Fibrosis Studies

Advanced research into Progressive Fibrosing Interstitial Lung Diseases and related conditions. Studies are evaluating new therapeutic agents for long-term management and improvement of lung function.

  • Idiopathic Pulmonary Fibrosis
  • Progressive Pulmonary Fibrosis
  • Lung Function Assessment

Trials aim to address the progression of fibrotic lung conditions and enhance treatment options.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).